Artwork

Indhold leveret af Mayo Clinic Laboratories. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Mayo Clinic Laboratories eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !

Panel Detects Demyelinating Neuropathy Biomarkers: John Mills, Ph.D., and Divyanshu Dubey, M.B.B.S.

14:11
 
Del
 

Manage episode 440359559 series 2908385
Indhold leveret af Mayo Clinic Laboratories. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Mayo Clinic Laboratories eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

John Mills, Ph.D., and Divyanshu Dubey, M.B.B.S., explain how Mayo Clinic Laboratories' new test panel can distinguish among various potential causes of demyelinating neuropathies. Test results are important for managing these devastating autoimmune conditions.

Show notes

Speaker 3: (00:32)
Would you provide a little background on yourself, Dr. Mills?

Speaker 3: (01:19)
Dr. Dubey?

Speaker 3: (02:07)
Can you give a brief overview of our demyelinating test and recommended use?

Speaker 3: (03:52)
Can you discuss how this new test will assist in a patient's journey?

Speaker 3: (05:46)
Can you tell us some of the unique features of this test?

Speaker 3: (08:09)
Dr. Dubey, as a neurologist, how does this test set us apart in the market?

Speaker 3: (11:05)
Could you summarize the benefits of having both a demyelinating panel and an axonal panel?

Speaker 3: (11:40)
Why should a patient have an axonal or demyelinating test versus a sensory and motor test for peripheral neuropathy?

  continue reading

333 episoder

Artwork
iconDel
 
Manage episode 440359559 series 2908385
Indhold leveret af Mayo Clinic Laboratories. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Mayo Clinic Laboratories eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

John Mills, Ph.D., and Divyanshu Dubey, M.B.B.S., explain how Mayo Clinic Laboratories' new test panel can distinguish among various potential causes of demyelinating neuropathies. Test results are important for managing these devastating autoimmune conditions.

Show notes

Speaker 3: (00:32)
Would you provide a little background on yourself, Dr. Mills?

Speaker 3: (01:19)
Dr. Dubey?

Speaker 3: (02:07)
Can you give a brief overview of our demyelinating test and recommended use?

Speaker 3: (03:52)
Can you discuss how this new test will assist in a patient's journey?

Speaker 3: (05:46)
Can you tell us some of the unique features of this test?

Speaker 3: (08:09)
Dr. Dubey, as a neurologist, how does this test set us apart in the market?

Speaker 3: (11:05)
Could you summarize the benefits of having both a demyelinating panel and an axonal panel?

Speaker 3: (11:40)
Why should a patient have an axonal or demyelinating test versus a sensory and motor test for peripheral neuropathy?

  continue reading

333 episoder

Alle episoder

×
 
Loading …

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Hurtig referencevejledning